| | | | | |
ANIK Anika Therapeutics Inc | $21,9460 | +1,74% | $294,82M | $55,00 | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | $10,5050 | +0,24% | $294,73M | $397,00 | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | $10,0150 | -0,25% | $294,68M | $314,00 | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | $43,2650 | +0,24% | $294,53M | $1,04K | |
| $44,7570 | -0,87% | $294,35M | $1,000 | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | $10,0190 | +0,19% | $294,35M | $100,01K | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | $10,0700 | -0,10% | $294,33M | $187,00 | |
SLN Silence Therapeutics Plc American Depository Share | $14,2000 | +0,71% | $294,27M | $5,80K | |
MTNE CH4 Natural Solutions Corporation | $9,8750 | +0,04% | $293,88M | $6,000 | |
RXST RxSight, Inc. Common Stock | $6,3500 | -0,31% | $293,64M | $4,72K | |
NHIC NewHold Investment Corp III Class A Ordinary shares | $10,7000 | +0,47% | $293,52M | $438,00 | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | $10,0050 | +0,00% | $293,49M | $86,47K | |
CNXU Conexeu Sciences Inc. Common Stock | $10,1000 | +1,10% | $293,27M | $2,48K | |
| $10,0720 | +0,82% | $292,98M | $1,85K | |
JCE Nuveen Core Equity Alpha Fund | $17,0800 | +0,00% | $292,78M | $22,90K | |
